JW (Cayman) Therapeutics Co. Ltd (2126.HK) HKSE

3.57

-0.13(-3.51%)

Updated at November 14 03:36PM

Currency In HKD

Valuation

Market Cap497.26M
Enterprise Value162.29M
P/E Ratio-2.19
PEG Ratio0.52
Price/Sales Ratio7.62
Price/Book Ratio1.49
Enterprise/Revenue6.07
Enterprise/EBITDA-4.21

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-3.47
Operating Margin0.73

Management Effectiveness

Return On Assets-0.44
Return On Equity-0.59

Income Statement

Revenue158.22M
Revenue/Share0.43
Gross Profit77.32M
EBITDA-381.58M
Net Income-590.62M
Diluted EPS-1.43

Balance Sheet

Total Cash647.04M
Total Cash/Share1.56
Total Debt372.46M
Total Debt/Equity0.41
Current Ratio1.59
Book Value Per Share2.19

Price History

52-Week Change170.45
52-Week High6.44
52-Week Low1.23
Moving Average 50 Days4.25
Moving Average 200 Days3.06

Statistics

Average Volume3.38M
Shares Outstanding415.3M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A